Back to Results
First PageMeta Content
Atypical antipsychotics / Piperazines / Organochlorides / Lactams / Piperidines / Antipsychotic / Olanzapine / Risperidone / Extrapyramidal symptoms / Chemistry / Psychiatry / Organic chemistry


AJP in Advance. Published September 15, 2008 (doi: [removed]appi.ajp[removed]Article Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizoaffective Disorder
Add to Reading List

Document Date: 2008-09-26 18:04:52

Open Document

File Size: 3,89 MB

Share Result on Facebook

City

Boca Raton / Mean / Seattle / Boston / Washington / D.C. / Cleveland / Bethesda / /

Company

Eli Lilly / RisperidoneGroup / Olanzapine Group / Group (N= 40) Olanzapine Group (N= 35) Risperidone Group / QTcchange (msec) Molindone Group / Pfizer / Eli Lill / AstraZeneca / Bristol -Myers Squibb / /

/

Event

FDA Phase / /

Facility

National Institute of Mental Health / McLean Hospital / Columbia University / American College of Neuropsychopharmacology / University of Washington / Case Western Reserve University / University of North Carolina / Chapel Hill / Maine Medical Center Research Institute / /

IndustryTerm

treatment / Treatment of Early-Onset Schizophrenia Spectrum Disorders / Treatment of EarlyOnset Schizophrenia Spectrum Disorders / outpatient services / /

MedicalCondition

Early-Onset Schizophrenia Spectrum Disorders / mild tardive dyskinesia / Subjects With Early-Onset Schizophrenia / ANTI PSYCHOTICS IN EARLY-ONSET SCHIZOPHRENIA / hyperinsulinemia / urinary retention / concomitant mood disorder / schizophreniform disorder / schizoaffect ive disorder / adult-onset schizophrenia / Schizoaffective Disorder / chronic samples / ajp.psychiatryonline.org fective disorder / obesity / schizo affective disorder / mood disorders / Drug-Induced Akathisia / psychosocial dysfunction / illness / constipation / tive disorder / episode schizophrenia / both first-episode and chronic early-onset schizophrenia / Insomnia / early-o nset schizophrenia / mental retardation / treatment-resistant schizophrenia / Drug- Induced Akathisia / schizophrenia / chronic / dyslipidemia / ANTIPSYCHOTICS IN EARLY-ONSET SCHIZOPHRENIA / cardiovascular disease / diabetes / schizoph reniform disorder / involuntary movements / Early-Onset Schizophrenia / SCID / dystonia / tardive dyskinesia / non psychotic disorders / behavioral disorders / syndrome / akathisia / /

NaturalFeature

Chapel Hill / /

Organization

Harvard Medical School / NIMH's Data and Safety Monitoring Board / University of Washington / University of North Carolina / Case Western Reserve University / Cambridge Health Alliance / McLean Hospital / Columbia University / New York / Data and Safety Monitoring Board / American Psychiatric Association / U.S. Food and Drug Administration / the American College / NIMH's Data and SafetyMonitoring Board / Maine Medical Center Research Institute / American Academy of Child and Adolescent Psychiatry / University of Wash / New Clinical Drug Evaluation Unit / National Institute of Mental Health / /

Person

TRIG AST ALT / B.A. Denisse Ambler / D. Robert M. Hamer / HOMA-IR / C.S. Stefanie Hlastala / D. Madeline Puglia / D. Emily Michael / D. Denise Delporto-Bedoya / M.D. Benedetto Vitiello / A. Ann E. Maloney / A. Frazier / D. Robert Anderson / Slifka / Psychiotry Sikich / C.S. Nancy Noyes / H. Nora K. McNamara / Robert L. Findling / /

/

Position

consultant / child psychiatrist / forward / /

Product

haloperidol / loxapine / carbamazepine / risperidone / olanzapine / Clozapine / M-9 / valproic acid / perphenazine / treatment / /

ProvinceOrState

Alabama / Maryland / New York / Scarborough / Florida / North Carolina / /

PublishedMedium

Neuropsychopharmacology / /

Technology

CGI / dom / ado / /

SocialTag